Photo from Envato
Its growth is attributed to a rise in infectious diseases.
The global self-amplifying ribonucleic acid (RNA) synthesis market is projected to reach $310.8m by 2030 at a compound annual growth rate of 19.24%, according to Research and Markets.
The sector’s expansion is attributed to an upsurge in infectious diseases and the rising demand for RNA-based vaccines and therapies, and personalised medicine.
“Beyond vaccines, saRNA shows promise across cancer, genetic disorders, and autoimmune diseases,” the report said.
Meanwhile, continuous advancements in RNA technology, coupled with the increasing number of clinical trials, are expected to drive further market growth.
Join
Healthcare Asia Magazine
community
Since you’re here…
…there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.
We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.
Let us help you drive your business forward with a good partnership!
